| Rayhan Adi Lal, MD | |
|
300 Pasteur Dr, Stanford, CA 94305-2200 | |
| (650) 723-4000 | |
| Not Available |
| Full Name | Rayhan Adi Lal |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 13 Years |
| Location | 300 Pasteur Dr, Stanford, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083846166 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stanford Health Care | Stanford, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stanford Health Care | 6709797491 | 2572 |
News Archive
Plans are afoot next year for British surgeons to attempt to make the first repairs of spinal cord nerves using a revolutionary new stem cell technique.
Coro Health, LLC, a provider of technology-based wellness therapies designed to improve the quality of life for seniors and caregivers, today announced it has been recognized as Program to Watch by the Assisted Living Federation of America 2011 Best of the Best Awards program.
Today, the U.S. Consumer Product Safety Commission (CPSC) joined three child safety organizations at NewYork-Presbyterian/Morgan Stanley Children's Hospital to release "Safe Sleep for Babies," a new crib safety video aimed at helping all new parents avoid suffocation, strangulation and entrapment risks in the sleep environment. CPSC also is announcing three new recalls of dangerous drop-side cribs.
Malignant gliomas are the most common subtype of primary brain tumor - and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to prostate, the most aggressive form of malignant glioma, called a glioblastoma multiforme or GBM, has steadfastly defied advances in neurosurgery, radiation therapy and various conventional or novel drugs. But an international team of scientists, headed by researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine, reports in the August 15 issue of Genes & Development that they have discovered a new signaling pathway between GBM cells - one that, if ultimately blocked or disrupted, could significantly slow or reduce tumor growth and malignancy.
› Verified 1 days ago
| Entity Name | Stanford Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437292927 PECOS PAC ID: 6709797491 Enrollment ID: O20031124000348 |
News Archive
Plans are afoot next year for British surgeons to attempt to make the first repairs of spinal cord nerves using a revolutionary new stem cell technique.
Coro Health, LLC, a provider of technology-based wellness therapies designed to improve the quality of life for seniors and caregivers, today announced it has been recognized as Program to Watch by the Assisted Living Federation of America 2011 Best of the Best Awards program.
Today, the U.S. Consumer Product Safety Commission (CPSC) joined three child safety organizations at NewYork-Presbyterian/Morgan Stanley Children's Hospital to release "Safe Sleep for Babies," a new crib safety video aimed at helping all new parents avoid suffocation, strangulation and entrapment risks in the sleep environment. CPSC also is announcing three new recalls of dangerous drop-side cribs.
Malignant gliomas are the most common subtype of primary brain tumor - and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to prostate, the most aggressive form of malignant glioma, called a glioblastoma multiforme or GBM, has steadfastly defied advances in neurosurgery, radiation therapy and various conventional or novel drugs. But an international team of scientists, headed by researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine, reports in the August 15 issue of Genes & Development that they have discovered a new signaling pathway between GBM cells - one that, if ultimately blocked or disrupted, could significantly slow or reduce tumor growth and malignancy.
› Verified 1 days ago
| Entity Name | Lpch Medical Group Div Of Lucile |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417907940 PECOS PAC ID: 0840298543 Enrollment ID: O20061113000232 |
News Archive
Plans are afoot next year for British surgeons to attempt to make the first repairs of spinal cord nerves using a revolutionary new stem cell technique.
Coro Health, LLC, a provider of technology-based wellness therapies designed to improve the quality of life for seniors and caregivers, today announced it has been recognized as Program to Watch by the Assisted Living Federation of America 2011 Best of the Best Awards program.
Today, the U.S. Consumer Product Safety Commission (CPSC) joined three child safety organizations at NewYork-Presbyterian/Morgan Stanley Children's Hospital to release "Safe Sleep for Babies," a new crib safety video aimed at helping all new parents avoid suffocation, strangulation and entrapment risks in the sleep environment. CPSC also is announcing three new recalls of dangerous drop-side cribs.
Malignant gliomas are the most common subtype of primary brain tumor - and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to prostate, the most aggressive form of malignant glioma, called a glioblastoma multiforme or GBM, has steadfastly defied advances in neurosurgery, radiation therapy and various conventional or novel drugs. But an international team of scientists, headed by researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine, reports in the August 15 issue of Genes & Development that they have discovered a new signaling pathway between GBM cells - one that, if ultimately blocked or disrupted, could significantly slow or reduce tumor growth and malignancy.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rayhan Adi Lal, MD 300 Pasteur Dr, Stanford, CA 94305-2200 Ph: (650) 723-4000 | Rayhan Adi Lal, MD 300 Pasteur Dr, Stanford, CA 94305-2200 Ph: (650) 723-4000 |
News Archive
Plans are afoot next year for British surgeons to attempt to make the first repairs of spinal cord nerves using a revolutionary new stem cell technique.
Coro Health, LLC, a provider of technology-based wellness therapies designed to improve the quality of life for seniors and caregivers, today announced it has been recognized as Program to Watch by the Assisted Living Federation of America 2011 Best of the Best Awards program.
Today, the U.S. Consumer Product Safety Commission (CPSC) joined three child safety organizations at NewYork-Presbyterian/Morgan Stanley Children's Hospital to release "Safe Sleep for Babies," a new crib safety video aimed at helping all new parents avoid suffocation, strangulation and entrapment risks in the sleep environment. CPSC also is announcing three new recalls of dangerous drop-side cribs.
Malignant gliomas are the most common subtype of primary brain tumor - and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to prostate, the most aggressive form of malignant glioma, called a glioblastoma multiforme or GBM, has steadfastly defied advances in neurosurgery, radiation therapy and various conventional or novel drugs. But an international team of scientists, headed by researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine, reports in the August 15 issue of Genes & Development that they have discovered a new signaling pathway between GBM cells - one that, if ultimately blocked or disrupted, could significantly slow or reduce tumor growth and malignancy.
› Verified 1 days ago
Prista Charuworn, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr, Alway Build M211, Mc 5187, Stanford, CA 94305 Phone: 650-723-6661 | |
Yu Kuang Lai, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Andrea Lorenze, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Drive, Lane 154, Stanford, CA 94305 Phone: 650-723-6661 Fax: 650-498-6205 | |
Audra Horomanski, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 Fax: 650-498-6205 | |
Meghan Brady Marmor, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Lauren Michelle Ulsh, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Ann M Chen, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, A149, Mc5202, Stanford, CA 94305 Phone: 650-725-3376 Fax: 650-723-8305 |